• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjectsProfilesView

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Gonadal function following chemotherapy for childhood Hodgkin's disease.

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Authors
    Mackie, E J
    Radford, M
    Shalet, Stephen M
    Affiliation
    Department of Paediatric Oncology, The Christie Hospital, NHS Trust, Manchester, United Kingdom.
    Issue Date
    1996-08
    
    Metadata
    Show full item record
    Abstract
    Gonadal function was assessed in 101 postpubertal subjects after chemotherapy for childhood Hodgkin's disease. All had received ChlVPP (chlorambucil, vinblastine, procarbazine, and prednisolone) chemotherapy alone, with no radiotherapy below the diaphragm. Gonadotropin levels were available in 46 (79.3%) male and 32 (74.4%) female subjects. The mean age at diagnosis in the male cohort was 12.2 years (range 8.2-15.3) and in the females 13.0 years (9.0-15.2). The males and the females were studied at a median of 6 years (range 2.5-11.1) and 4.3 years (range 1.9-11.5) from diagnosis, respectively. Forty-one (89.1%) male subjects had elevated follicle-stimulating hormone (FSH) levels, confirming severe germinal epithelial damage. Germinal epithelial damage was seen in subjects up to 10 years out of therapy. Subtle Leydig cell dysfunction was identified in 24.4% with raised luteinzing hormone (LH) levels. All subjects, however, progressed spontaneously through puberty. Seventeen (53%) women had raised gonadotropin levels, with variable estradiol levels. Of these, 10 subjects presented with symptomatic ovarian failure and 6 received hormone replacement therapy (HRT). Nine women had 11 successful pregnancies, two of whom had previously had symptoms of ovarian failure with one requiring HRT. A much higher prevalence of ovarian failure has been observed, than has previously been considered in the prepubertal and pubertal female following combination chemotherapy. These conclusions have important implications for future counseling, management, and research in this population.
    Citation
    Gonadal function following chemotherapy for childhood Hodgkin's disease. 1996, 27 (2):74-8 Med. Pediatr. Oncol.
    Journal
    Medical and Pediatric Oncology
    URI
    http://hdl.handle.net/10541/95930
    DOI
    10.1002/(SICI)1096-911X(199608)27:2<74::AID-MPO2>3.0.CO;2-Q
    PubMed ID
    8649323
    Type
    Article
    Language
    en
    ISSN
    0098-1532
    ae974a485f413a2113503eed53cd6c53
    10.1002/(SICI)1096-911X(199608)27:2<74::AID-MPO2>3.0.CO;2-Q
    Scopus Count
    Collections
    All Christie Publications

    entitlement

    Related articles

    • Gonadal function following chemotherapy for Hodgkin's disease: a comparative study of MVPP and a seven-drug hybrid regimen.
    • Authors: Clark ST, Radford JA, Crowther D, Swindell R, Shalet SM
    • Issue date: 1995 Jan
    • Testicular function following the treatment of Hodgkin's disease in childhood.
    • Authors: Shafford EA, Kingston JE, Malpas JS, Plowman PN, Pritchard J, Savage MO, Eden OB
    • Issue date: 1993 Dec
    • Gonadal function in prepubertal boys following treatment for Hodgkin's disease.
    • Authors: Dhabhar BN, Malhotra H, Joseph R, Garde S, Bhasin S, Sheth A, Advani SH
    • Issue date: 1993 Aug
    • Gonadal function and fertility in male survivors treated for Hodgkin's disease in Iran.
    • Authors: Rafsanjani KA, Faranoush M, Hedayatiasl AA, Vossough P
    • Issue date: 2007 Nov
    • Inhibin B is superior to FSH as a serum marker for spermatogenesis in men treated for Hodgkin's lymphoma with chemotherapy during childhood.
    • Authors: van Beek RD, Smit M, van den Heuvel-Eibrink MM, de Jong FH, Hakvoort-Cammel FG, van den Bos C, van den Berg H, Weber RF, Pieters R, de Muinck Keizer-Schrama SM
    • Issue date: 2007 Dec
    DSpace software (copyright © 2002 - 2025)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.